| Application no. and date | 23726545.9 (espacenet) (Federated) (European Patent Register), 20230519 | | Patent/reg. no. and date | DK/EP 4526683, 20251203 | | Publication date | 20250326 | | Priority no. and date | FI 20225445, 20220520, FI 20225962, 20221026 | | EP pub. no. and date |
EP 4526683 20250326 | | Effective date | | | Applicant/owner | Faron Pharmaceuticals OY, Joukahaisenkatu 6
20520 Turku, FI | | Applicant ref. no. | P87570DK01 | | Inventor | JALKANEN, Juho,
23120 MIETOINEN, FI,
BJÖRKMAN, Mari,
20720 Turku, FI,
HOLLMÉN, Maija-Leena,
20760 Piispanristi, FI | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | G01N 33/574 (2006.01) | | Title | FREMGANGSMÅDE TIL IDENTIFICERING AF CANCERPATIENTER, DER HAR GAVN AF ANTI-CLEVER-1-BEHANDLING | | Int. application no. | FI2023050280 | | Int. publication no. | WO2023222953 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
